Trials / Completed
CompletedNCT05015998
A Study to Evaluate the ePidemiology of anEmia Associated With chroNic Kidney Disease in Patients in Primary Care Using The Stockholm CREAtinine Measurement (SCREAM) Register
A Non-interventional Evaluation of the ePidemiology of anEmia Associated With chroNic Kidney Disease in Patients in Primary Care Using The Stockholm CREAtinine Measurement (SCREAM) Register
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 45,637 (actual)
- Sponsor
- Astellas Pharma Europe Ltd. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objectives of this analysis is to determine the incidence of anemia occurring in patients with chronic kidney disease (CKD) in primary care (i.e. prior to any eventual referral to nephrology care). This analysis also evaluates patient characteristics, anemia treatment and associated cardiovascular risk.
Detailed description
Data will be derived from the Stockholm CREATinine Measurement (SCREAM) cohort, a repository of laboratory data of individuals residing and accessing healthcare in the region of Stockholm and who underwent a creatinine assessment between 2012 - 2018.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Non-interventional | Epidemiology of anemia associated with chronic kidney disease, rather than to evaluate specific drugs |
Timeline
- Start date
- 2021-11-30
- Primary completion
- 2021-11-30
- Completion
- 2021-11-30
- First posted
- 2021-08-23
- Last updated
- 2024-10-31
Locations
1 site across 1 country: Sweden
Source: ClinicalTrials.gov record NCT05015998. Inclusion in this directory is not an endorsement.